ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,195Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 1006

$758K Total Retail Price of All Prescriptions

Rank: 92 out of 1006

421 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 421 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 421 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 10,197 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 516 399 1 2
SIMVASTATIN 506 416 2 1
LISINOPRIL 406 324 3 3
WARFARIN SODIUM 379 379 4 8
FUROSEMIDE 337 287 5 6
METFORMIN HCL 316 252 6 10
METOPROLOL TARTRATE 309 289 7 7
AMLODIPINE BESYLATE 264 219 8 4
NAMENDA 250 250 9 34
PRAVASTATIN SODIUM 236 214 10 15
SERTRALINE HCL 228 215 11 19
ATORVASTATIN CALCIUM 227 178 12 5
DONEPEZIL HCL 221 208 13 17
HYDROCHLOROTHIAZIDE 215 200 14 11
ZOLPIDEM TARTRATE 200 133 15 14
POTASSIUM CHLORIDE 186 168 16 30
CARVEDILOL 158 145 17 36
HYDROCODONE-ACETAMINOPHEN 149 70 S3 18 25
NEXIUM 143 114 19 28
ESCITALOPRAM OXALATE 141 115 20 27
ALENDRONATE SODIUM 136 124 21 29
METOPROLOL SUCCINATE 127 113 22 12
MIRTAZAPINE 119 116 23 26
JANUVIA 116 93 24 49
ATENOLOL 116 112 24 13
LANTUS 111 109 26 43
OMEPRAZOLE 105 105 27 9
CLOPIDOGREL 103 101 28 46
ALLOPURINOL 93 90 29 31
TAMSULOSIN HCL 91 82 30 23
SPIRIVA 89 73 31 48
CRESTOR 88 45 32 18
TORSEMIDE 88 88 32 188
DIOVAN 87 87 34 16
ADVAIR DISKUS 83 68 35 37
TRAZODONE HCL 79 57 36 21
PLAVIX 75 75 37 61
OXYCODONE HCL 72 39 S2 38 54
ZETIA 71 46 39 51
SPIRONOLACTONE 68 68 40 71
CITALOPRAM HBR 65 53 41 24
PANTOPRAZOLE SODIUM 63 50 42 32
QUETIAPINE FUMARATE 62 52 43 45
CYMBALTA 60 55 44 41
GABAPENTIN 60 30 44 20
LEVETIRACETAM 58 34 46 72
CYCLOBENZAPRINE HCL 58 31 R 46 113
OXYCODONE-ACETAMINOPHEN 57 52 S2 48 57
GENERLAC 57 57 48 140
LIPITOR 56 35 50 47
RISPERIDONE 56 45 50 40
SYNTHROID 56 47 50 42
PROAIR HFA 55 17 53 64
HUMALOG 52 48 54 116
DILTIAZEM 24HR CD 52 52 54 88
METFORMIN HCL ER 51 33 56 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.